{"id":50350,"date":"2022-11-01T19:02:35","date_gmt":"2022-11-01T18:02:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-pharmaceutical-contract-manufacturing-market-report-2022-growing-need-for-state-of-the-art-processes-and-production-technologies-driving-sector-researchandmarkets-com\/"},"modified":"2022-11-01T19:02:35","modified_gmt":"2022-11-01T18:02:35","slug":"global-pharmaceutical-contract-manufacturing-market-report-2022-growing-need-for-state-of-the-art-processes-and-production-technologies-driving-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-pharmaceutical-contract-manufacturing-market-report-2022-growing-need-for-state-of-the-art-processes-and-production-technologies-driving-sector-researchandmarkets-com\/","title":{"rendered":"Global Pharmaceutical Contract Manufacturing Market Report 2022: Growing Need for State-Of-The-Art Processes and Production Technologies Driving Sector – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Contract Manufacturing Market Research and Forecast 2022-2028”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global market for pharmaceutical contract manufacturing is projected to have a considerable CAGR of around 6.9% during the forecast period. All pharmaceutical companies operate as outsourcing companies, dealing with the development and manufacturing of drugs, which leads to business scalability and revenue, which allows for the development of new drugs. The growing need for state-of-the-art processes and production technologies, which have proven highly effective in meeting regulatory requirements, is the most important factor driving the growth of CMOs in the pharmaceutical industry.\n<\/p>\n

\nThe increasing number of cell therapy candidates, combined with their steady growth through the various stages of clinical development and their complicated manufacturing process, drives up demand for manufacturing services for these therapies. Therefore, this factor creates an opportunity for market growth. However, the dynamic changes seen in this sector, combined with extreme margin pressure, are expected to restrict growth significantly.\n<\/p>\n

\nSegmental Outlook<\/strong>\n<\/p>\n

\nThe global pharmaceutical contract manufacturing market is segmented based on category, type, product and service. Based on the category the market is further classified into human-based drugs and animals-based drugs. On the basis of type, the market is further segregated into sterile manufacturing and non-sterile manufacturing. Further on the basis of product, the market is classified into over-the-counter (OTC) drugs, active pharmaceutical ingredients (API), finished dosage formulation and others (nutritional products and packaging) and based on services the market is segmented into manufacturing services, non-clinical services, and research & development.\n<\/p>\n

\nGlobal Pharmaceutical Contract Manufacturing Market to be driven by active pharmaceutical ingredients (API).\n<\/p>\n

\nAmong products, the active pharmaceutical ingredients (API), the segment is projected to hold a considerable share in the market owing to factors such as the rising prevalence of chronic diseases including cardiovascular diseases and cancer and increasing advancements in active pharmaceutical ingredient (API) manufacturing. The API segment is experiencing significant changes as a result of the supply chain disruption caused by COVID-19.\n<\/p>\n

\nDue to geopolitical situations and the desire to reduce dependence on China for API products, countries such as India are being preferred over China for API export. Furthermore, pharmaceutical firms benefit from API production outsourcing because it eliminates the need for costly manufacturing unit installation and labor force. However, unfavorable drug pricing policies in various countries, as well as high manufacturing costs, are expected to restrain the segment growth.\n<\/p>\n

\nThe Report Covers<\/strong>\n<\/p>\n